STC Life Co., Ltd Successfully Treats Canadian Pulmonary Fibrosis Patient At 97.7 B&H Hospital Stem Cell Center
3/12/2014 8:48:43 AM
SEOUL, South Korea--(BUSINESS WIRE)--Stem cell research institute of STC Life Co., Ltd. (Chairman: KYE HO LEE) and 97.7 B&H Clinic (Representative Doctor: WON JU JUNG) successfully finished mesenchymal stem cell therapy for the pulmonary fibrosis patient who visited Korea from Calgary, Canada. Pulmonary fibrosis is a disease caused by overproduction of fibrous tissues while lung tissues are consistently being destroyed. As scar tissues gradually spread to entire lung, oxygen uptake is reduced, which causes difficulty in breathing. It is a kind of autoimmune diseases that attacks the patient’s immune system of his or her own tissues. In particular, it is reported that pulmonary fibrosis is frequently found in patients with a severe autoimmune disease.
Help employers find you! Check out all the jobs and post your resume.
comments powered by